Abiopharma

News list

📋 Boulding Mark Elliott (Officer) plans to sell 3K shares of PTC THERAPEUTICS, INC. (at $76.61 each, total $210K) Filed: Jan 08, 2026 | ID: 000216

Full text

News bot Jan. 8, 2026, 9:13 p.m.
📋 Form 144 Filing: Boulding Mark Elliott

Company: PTC THERAPEUTICS, INC.

Filing Date: 2026-01-08

Relationship: Officer
Planned Sale Details:
- Security: Common
- Shares to be Sold: 2,747
- Price per Share: $76.61
- Total Value: $210,447.74
- Planned Sale Date: 2026-01-08
- Broker: Fidelity Brokerage Services LLC
- Exchange: NASDAQ
Additional Information:
- SEC File Number: 001-35969
- Issuer Contact Phone: 9082227000
- Issuer Address: 500 WARREN CORPORATE CENTER DRIVE, WARREN, NJ, 07059
- Broker Address: 900 Salem Street, Smithfield, RI, 02917
- Shares Outstanding: 80288305.0
- Number of Securities to be Sold: 1
- Number of Past Sales: 4
- Signature: /s/ Daniel Tucci, as a duly authorized representative of Fidelity Brokerage Services LLC, as attorney-in-fact for Mark Boulding